Fact Sheet
IQVIA Early Phase Oncology Network (EPON)
May 19, 2023

Novel therapies for cancer patients can come with a more complex development path. More defined target patient populations are often needed and harder to find. The landscape of early phase oncology drug development is evolving, adding more pressure on study timelines and mitigating risks. IQVIA has end-to-end solutions in early phase oncology to help sponsors to adapt to the paradigm shift.

IQVIA's Early Phase Oncology Network (EPON) is a global network of qualified Phase I oncology sites working in close alignment for fast site activation and better patient recruitment. By utilizing pre-identified experienced sites, site selection timelines can be reduced, increasing operational efficiencies.

Related solutions

Contact Us